Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials

Statistical Methods for Rates and Proportions

2003 • 17,930 citations

Longitudinal data analysis using generalized linear models

1986 • 17,084 citations

Statistical Methods for Rates and Proportions.

1981 • 8,945 citations

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1981 • 3,549 citations

Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

1989 • 1,658 citations

Recombinant Interferon Alfa Therapy for Chronic Hepatitis C

1989 • 1,233 citations

Methods for combining randomized clinical trials: Strengths and limitations

1987 • 998 citations

Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon

1986 • 980 citations

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

1996 • 675 citations

A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B Hepatitis

1995 • 465 citations

Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France

1991 • 320 citations

Interferon for non-A, non-B chronic hepatitis

1991 • 294 citations

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis

1991 • 253 citations

Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial

1996 • 123 citations

Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates

1995 • 121 citations

Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C

1995 • 102 citations

A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis

1990 • 95 citations

A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs

1991 • 93 citations

Prolonged treatment (18 months) of chronic hepatitis C with recombinant α-interferon in comparison with a control group

1990 • 74 citations

A Randomized Controlled Open Study of Interferon Alpha-2b Treatment of Chronic IMon-A, Non-B Posttransfusion Hepatitis: No Correlation of Outcome to Presence of Hepatitis C Virus Antibodies

1989 • 73 citations

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

1996 • 72 citations

Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?

1991 • 43 citations

The Use of Recombinant Interferon Alfa‐2b in Elderly Patients with Anti‐HCV‐Positive Chronic Active Hepatitis

1993 • 38 citations

Interferon-α Treatment in Patients with Chronic Hepatitis C

1995 • 36 citations

Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non‐A, non‐B (C) hepatitis

1993 • 34 citations

A controlled study to determine the optimal dose regimen of interferon-alpha 2b in chronic hepatitis C.

1995 • 33 citations

Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose

1996 • 32 citations

Changes of serum 2‘,5’-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis C

1993 • 28 citations

Dose increase augments response rate to interferon-α in chronic hepatitis C

1996 • 28 citations

Effect of Recombinant or Lymphoblastoid Interferon-α on Alanine Aminotransferase in Patients with Chronic Hepatitis C or Chronic Non-A Non-B Hepatitis

1995 • 26 citations

Histologic Changes in Liver Biopsy Specimens Produced by Recombinant Interferon α-2b Therapy for Chronic Non-A,Non-B Viral Hepatitis: A Randomized Controlled Trial

1992 • 23 citations

Randomized Controlled Trial of Recombinant Interferon-α_2b in the Treatment of Chinese Patients with Chronic Hepatitis C

1995 • 20 citations

Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial.

1996 • 20 citations

Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment.

1993 • 19 citations

Alpha interferon treatment of chronic hepatitis C

1995 • 19 citations

Hepatitis C virus RNA and long‐term response to recombinant interferon‐α2b in patients with chronic hepatitis C

1995 • 16 citations

Low-dose interferon in chronic hepatitis non-A/non-B: effects on quantitative liver function and structure in a randomized, controlled multicenter trial

1993 • 15 citations

Alpha-lnterferon Treatment of Chronic Hepatitis C: A Controlled, Multicentre, Prospective Study

1995 • 14 citations

Fixed versus titrated interferon-α2B in chronic hepatitis C. A randomized controlled multicenter trial

1996 • 14 citations

Treatment of chronic hepatitis C with recombinant interferon alfa-2b for nine months.

1993 • 11 citations

Treatment of Chronic Hepatitis C with Recombinant Interferon Alpha 2b

1992 • 10 citations

Two Dose Regimens of Recombinant Interferon-Alpha-2b in Chronic Hepatitis C Virus Infection: Biochemistry, Hepatitis C Virus RNA, and Liver Histology as Response Indices

1995 • 10 citations

Nizatidine in the treatment of acute gastric ulcer: a multicenter trial.

1994 • 7 citations

The Randomized Controlled Trial

2006 • 6 citations

[Therapy of chronic non-A, non-B hepatitis with interferon alfa-2B. A controlled clinical study and long-term follow-up].

1991 • 5 citations

[Recombinant alpha 2b interferon in the treatment of chronic viral hepatitis C: comparison of 2 schemes, classical and high-dosage].

1995 • 2 citations